Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOVASTATIN | 40MG | TABLET | Resolved | 2020-01-21 | 2024-03-02 | 103759 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-04-28 | 2021-12-07 | 138161 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-09-30 | 2021-12-07 | 146477 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2022-12-16 | 2023-01-23 | 178647 |
| CIPROFLOXACIN | 250MG | TABLET | Actual shortage | 2023-11-22 | 2024-04-29 | 211197 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72248 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-04-28 | 2021-10-27 | 138164 |
| CIPROFLOXACIN | 500MG | TABLET | Resolved | 2022-01-18 | 2023-01-23 | 152957 |
| CIPROFLOXACIN | 500MG | TABLET | Actual shortage | 2023-11-22 | 2024-05-03 | 211200 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2017-10-13 | 2017-11-10 | 25856 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-02-21 | 2018-03-09 | 40452 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2024-01-30 | 2024-03-02 | 217793 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-10-31 | 2017-11-10 | 27549 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-07-18 | 2023-09-25 | 198904 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-11-28 | 2017-12-16 | 30910 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-05-06 | 2019-06-28 | 83143 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-07-18 | 2023-08-28 | 198907 |
| METFORMIN | 500MG | TABLET | Resolved | 2023-08-29 | 2023-09-19 | 203144 |
| CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |